Chinese investigators traced the source of a chemical that contaminated the water supply of 2.4 million people to a leak from an oil pipeline run by a unit of China National Petroleum Corp., the Xinhua News Agency said.
Developing countries are seeking to pay as little as 1 percent of the $84,000 price Gilead Sciences Inc. is charging U.S. patients for its new hepatitis C drug. Wealthier countries such as Ukraine and China may not be so lucky, according to Doctors Without Borders, the nonprofit international aid group.
The cost of newer hepatitis C treatments, as high as $84,000 in the U.S., is unaffordable for most patients and must be lowered, the World Health Organization said in a report today providing guidelines for the screening, care and treatment of people with the virus.
Natalie Tennant, the presumptive Democratic nominee for West Virginia’s open U.S. Senate seat, got an earful visiting a company where workers said President Barack Obama’s environmental policies threaten their jobs.
Express Scripts Holding Co., a pharmacy benefit manager that handles more than 1 billion prescriptions annually in the U.S., is ratcheting up its effort to force Gilead Sciences Inc. to cut the $84,000 price of its new hepatitis C pill Sovaldi.